25/06/2025
📢 Mounjaro (Tirzepatide) – Weight Loss Use
You may have seen recent news about Mounjaro (tirzepatide) becoming available on the NHS for weight loss.
To clarify:
➡️ While Mounjaro is already used in the NHS for managing type 2 diabetes, its use for weight loss is being introduced in a very limited way, with strict national and local restrictions.
➡️ At present, there is no local prescribing pathway in place through North East and North Cumbria ICB, which means:
❗ We are not currently able to prescribe Mounjaro for weight loss at this GP surgery.
❗ Please do not book an appointment to request this medication, as we are unable to issue it at this time.
For awareness, the initial NHS rollout of Mounjaro for weight loss will only consider patients who meet all of the following criteria:
BMI of 40 or above (or 37.5 or above for some ethnic minority groups),
Plus at least four of the following health conditions:
High blood pressure
High cholesterol
Type 2 diabetes
Sleep apnoea
Heart disease
Even if you meet these criteria, access will be via a specialised local pathway once it is in place. At present it is not yet available, or set up via the ICB.
We’ll provide updates as soon as local guidance changes. Thank you for your understanding and support.
